Medical Diagnostic Laboratories, L.L.C., Fights Tick- and Mosquito-borne Epidemic with New Comprehensive Testing for Vector-borne Disease.

Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.

Genesis Biotechnology Group announces partnership with Yale University

Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer

Abstract accepted for Presentation at The Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting April 29 – May 03, 2018 in Honolulu, Hawaii

Invivotek Maintains Full AAALAC Accreditation for Excellence in Animal Care and Use

Genesis Biotechnology Group® Acquires Assets of 4path, Ltd to Expand their Diagnostic Branch

Invivotek Completes Solar Farm and Facility Expansion

Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima

Mercer County Community College has launched a partnership with GBG to give students the opportunity to work while they learn

Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Test

Medical Diagnostic Laboratories, L.L.C.’s The Institute for Biomarker Research Announces New Prenatal Cystic Fibrosis Tests

Invivotek is Awarded Full AAALAC Accreditation for Excellence in Animal Care and Use

Biotech Company Sponsors International Bacterial Vaginosis Symposium to Continue Support of Women’s Health

Mercer Regional Chamber of Commerce 2011 Award

Announcing new testing for Aerobic Vaginitis (AV).

A Complimentary Reflex Test to Determine Metronidazole Resistance in Trichomonas vaginalis.

New Bacterial Vaginosis/Lactobacillus Profiling Assay

New HPV-16 Status Test